相似文献
1
Ranolazine for Atrial Fibrillation: Too Good to be True?
J Atr Fibrillation. 2010 Aug 23;3(2):297. doi: 10.4022/jafib.297. eCollection 2010 Aug-Sep.
2
Comparison of vernakalant and ranolazine in atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2017 Sep;18(9):663-668. doi: 10.2459/JCM.0000000000000545.
3
Ranolazine for the prevention or treatment of atrial fibrillation: a systematic review.
J Cardiovasc Med (Hagerstown). 2014 Mar;15(3):254-9. doi: 10.2459/JCM.0b013e328365b554.
4
Ranolazine Prevents Levosimendan-Induced Atrial Fibrillation.
Pharmacology. 2018;102(3-4):138-141. doi: 10.1159/000490572. Epub 2018 Jul 6.
5
Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
Europace. 2015 Jan;17(1):32-7. doi: 10.1093/europace/euu217. Epub 2014 Sep 10.
6
Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study.
Heart Rhythm. 2015 May;12(5):872-8. doi: 10.1016/j.hrthm.2015.01.021. Epub 2015 Jan 17.
7
Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels.
Front Pharmacol. 2019 Nov 26;10:1367. doi: 10.3389/fphar.2019.01367. eCollection 2019.
8
Use of ranolazine in the prevention and treatment of postoperative atrial fibrillation in patients undergoing cardiac surgery.
Ann Pharmacother. 2014 May;48(5):633-7. doi: 10.1177/1060028014523257. Epub 2014 Feb 12.
9
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1048-56. doi: 10.1161/CIRCEP.115.002856. Epub 2015 Jul 30.
10
Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
J Cardiovasc Pharmacol. 2010 Mar;55(3):286-91. doi: 10.1097/FJC.0b013e3181d26416.
本文引用的文献
1
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
J Am Coll Cardiol. 2010 May 25;55(21):2299-307. doi: 10.1016/j.jacc.2010.01.043.
2
Managing atrial fibrillation: catheter ablation or antiarrhythmic therapy?
Circ Arrhythm Electrophysiol. 2009 Dec;2(6):599-602. doi: 10.1161/CIRCEP.109.922674.
3
Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation.
Clin Cardiol. 2009 Oct;32(10):544-8. doi: 10.1002/clc.20669.
4
The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.
Indian Pacing Electrophysiol J. 2009 Sep 1;9(5):260-7.
5
Dronedarone for atrial fibrillation: a new therapeutic agent.
Vasc Health Risk Manag. 2009;5:635-42. doi: 10.2147/vhrm.s6185. Epub 2009 Aug 6.
6
Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.
Mayo Clin Proc. 2009 Jul;84(7):643-62. doi: 10.1016/S0025-6196(11)60754-4.
7
The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation.
Indian Pacing Electrophysiol J. 2008 Aug 1;8(3):175-81.
8
Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
Pacing Clin Electrophysiol. 2008 Jun;31(6):765-8. doi: 10.1111/j.1540-8159.2008.01083.x.
9
Rationale and design of ATHENA: A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter.
J Cardiovasc Electrophysiol. 2008 Jan;19(1):69-73. doi: 10.1111/j.1540-8167.2007.01016.x. Epub 2007 Nov 21.
10
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
N Engl J Med. 2007 Sep 6;357(10):987-99. doi: 10.1056/NEJMoa054686.
Zotero 插件